Abstract
A series of novel 3-aryl-6-adamantylmethyl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles 6a–l were synthesized by a simple method with the aim of developing novel HIV non-nucleoside reverse transcriptase inhibitors. All the synthesized compounds were structurally confirmed by spectral analyses. The structure of 6a was unambiguously verified by X-ray structure determination. The synthesized compounds were evaluated for their anti-HIV activity and four analogs displayed moderate inhibitory activity with EC50 values ranging from 10.10 to 12.40 μg mL–1. Molecular docking of 6g with HIV-1 reverse transcriptase was studied to rationalize some structure-activity relationships (SARs).
摘要
一系列新型3-芳基-6-戊二醇基甲基-[1,2,4]三唑并[3,4-斜体b][1,3,4]噻二唑类化合物6a–l通过简单方法合成,旨在开发新型HIV非核苷逆转录酶抑制剂。所有合成的化合物均通过光谱分析得到结构确认。化合物6a的结构已通过X射线结构测定得到明确验证。合成的化合物被评估其抗HIV活性,其中四个类似物表现出中等抑制活性,EC50值在10.10至12.40 μg mL–1范围内。对6g与HIV-1逆转录酶的分子对接研究有助于理解一些结构活性关系(SARs)。